Jonathan Glenn

Chief Executive Officer

Appointed to the Board

11 September 2006. CEO with effect from December 2007

Current Role

Chief Executive Officer


Mr Glenn is a member of the Nomination Committee and the Sustainability Committee.

Key Strengths & Experience

Jonathan continues to demonstrate excellent leadership as CEO, leading the Group’s strategy and day to day management with an excellent understanding of the business, developed over the 11 years he has been CEO.

Jonathan was Group Finance Director of Consort Medical plc from September 2006 until December 2007 when he took up the position of Chief Executive Officer. Prior to joining Consort Medical plc, Jonathan was Global Head of Finance at Celltech Group plc and later Chief Financial Officer of Akubio Ltd, a Cambridge-based developer of instrumentation for the life sciences industry. Jonathan joined Tissue Regenix Group plc as a non-executive director in January 2016 and is an investor director of Binx Health Limited.

Jonathan is a member of the Institute of Chartered Accountants in England and Wales.

  • News
  • Case Studies
  • Pages
  • Blogs
  • Locations
  • Experts